---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-011699"
form_type: "8-K"
ticker: "APLS"
cik: "0001492422"
company_name: "Apellis Pharmaceuticals, Inc."
filed_at: "2024-01-22T23:59:59+00:00"
generated_at: "2026-06-06T20:37:11.143613+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Apellis appoints Adam Townsend as Chief Operating Officer, effective immediately

## Summary
- Adam Townsend, 47, previously Chief Commercial Officer since Nov 2018, assumes additional COO role.
- Townsend's background includes senior leadership roles at Biogen, including SVP of Corporate Development.
- No family relationships with directors or executive officers, and no reportable transactions.
- Appointment effective January 16, 2024, by the Board of Directors.

## SEC filing metadata
- accession: 0001193125-24-011699
- form_type: 8-K
- ticker: APLS
- cik: 0001492422
- company_name: Apellis Pharmaceuticals, Inc.
- filed_at: 2024-01-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1492422/000119312524011699/0001193125-24-011699-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1492422/000119312524011699/d696780d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-011699
- JSON: https://secwatch.observer/filing/0001193125-24-011699.json
- Plain text: https://secwatch.observer/filing/0001193125-24-011699.txt

## Key facts
- Executive change
  Adam Townsend was appointed as Chief Operating Officer at Apellis Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On January 16, 2024, the Board of Directors of Apellis Pharmaceuticals, Inc. (the “Company”) appointed Adam Townsend, the Company’s Chief Commercial Officer, to serve as the Company’s Chief Operating Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1492422/000119312524011699/0001193125-24-011699-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.